NORISTERAT

This brand name is authorized in Mexico, Nigeria, UK.

Active ingredients

The drug NORISTERAT contains one active pharmaceutical ingredient (API):

1	Norethisterone UNII HY3S2K0J0F - NORETHINDRONE ENANTHATE
	Norethisterone has progestational actions similar to those of progesterone, but is a more potent inhibitor of ovulation and has weak oestrogenic and androgenic properties. It is used to treat a number of disorders of the menstrual cycle.
	Read more about Norethisterone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NORISTERAT Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03AC01	Norethisterone	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AC Progestogens
Discover more medicines within G03AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	28170
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	86806
NG	Registered Drug Product Database	04-5715
Switch country to Nigeria in order to find specific presentations of NORISTERAT